STADA Arzneimittel Aktiengesellschaft Performance
The entity owns a Beta (Systematic Risk) of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and STADA Arzneimittel are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days STADA Arzneimittel Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, STADA Arzneimittel is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Fifty Two Week Low | 75.15 | |
Fifty Two Week High | 115.00 |
STADA |
STADA Arzneimittel Relative Risk vs. Return Landscape
If you would invest (100.00) in STADA Arzneimittel Aktiengesellschaft on January 24, 2024 and sell it today you would earn a total of 100.00 from holding STADA Arzneimittel Aktiengesellschaft or generate -100.0% return on investment over 90 days. STADA Arzneimittel Aktiengesellschaft is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than STADA, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
STADA Arzneimittel Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for STADA Arzneimittel's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as STADA Arzneimittel Aktiengesellschaft, and traders can use it to determine the average amount a STADA Arzneimittel's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
STDAF |
Based on monthly moving average STADA Arzneimittel is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of STADA Arzneimittel by adding STADA Arzneimittel to a well-diversified portfolio.
STADA Arzneimittel Fundamentals Growth
STADA OTC Stock prices reflect investors' perceptions of the future prospects and financial health of STADA Arzneimittel, and STADA Arzneimittel fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on STADA OTC Stock performance.
Return On Equity | 22.55 | |||
Return On Asset | 6.39 | |||
Profit Margin | 9.00 % | |||
Current Valuation | 6.87 B | |||
Shares Outstanding | 62.26 M | |||
Price To Earning | 22.46 X | |||
Price To Book | 4.54 X | |||
Price To Sales | 2.11 X | |||
Revenue | 2.69 B | |||
EBITDA | 559.98 M | |||
Cash And Equivalents | 502.02 M | |||
Cash Per Share | 8.06 X | |||
Total Debt | 1.73 B | |||
Debt To Equity | 2.58 % | |||
Book Value Per Share | 20.02 X | |||
Cash Flow From Operations | 347.14 M | |||
Earnings Per Share | 4.05 X | |||
Total Asset | 3.46 B | |||
Retained Earnings | 686 M | |||
Current Asset | 1.49 B | |||
Current Liabilities | 887 M | |||
Things to note about STADA Arzneimittel performance evaluation
Checking the ongoing alerts about STADA Arzneimittel for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for STADA Arzneimittel help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.STADA Arzneimittel is not yet fully synchronised with the market data | |
STADA Arzneimittel has some characteristics of a very speculative penny stock | |
STADA Arzneimittel has a very high chance of going through financial distress in the upcoming years |
- Analyzing STADA Arzneimittel's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether STADA Arzneimittel's stock is overvalued or undervalued compared to its peers.
- Examining STADA Arzneimittel's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating STADA Arzneimittel's management team can have a significant impact on its success or failure. Reviewing the track record and experience of STADA Arzneimittel's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of STADA Arzneimittel's otc stock. These opinions can provide insight into STADA Arzneimittel's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the STADA Arzneimittel information on this page should be used as a complementary analysis to other STADA Arzneimittel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in STADA OTC Stock
If you are still planning to invest in STADA Arzneimittel check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the STADA Arzneimittel's history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |